HAS 1: A natural product from soil-isolated Streptomyces species with potent activity against cutaneous leishmaniasis caused by Leishmania tropica.
Saved in:
| Title: | HAS 1: A natural product from soil-isolated Streptomyces species with potent activity against cutaneous leishmaniasis caused by Leishmania tropica. |
|---|---|
| Authors: | Awada B; Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.; Center for Drug Discovery, American University of Beirut, Beirut, Lebanon., Hamie M; Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.; Center for Drug Discovery, American University of Beirut, Beirut, Lebanon., El Hajj R; Department of Biological Sciences, Beirut Arab University, Beirut, Lebanon., Derbaj G; Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.; Center for Drug Discovery, American University of Beirut, Beirut, Lebanon., Najm R; College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates., Makhoul P; Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.; Center for Drug Discovery, American University of Beirut, Beirut, Lebanon., Ali DH; Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon., Abou Fayad AG; Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.; Center for Drug Discovery, American University of Beirut, Beirut, Lebanon., El Hajj H; Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.; Center for Drug Discovery, American University of Beirut, Beirut, Lebanon. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2022 Oct 10; Vol. 13, pp. 1023114. Date of Electronic Publication: 2022 Oct 10 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36299890 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: HAS 1: A natural product from soil-isolated Streptomyces species with potent activity against cutaneous leishmaniasis caused by Leishmania tropica. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Awada+B%22">Awada B</searchLink>; Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.; Center for Drug Discovery, American University of Beirut, Beirut, Lebanon.<br /><searchLink fieldCode="AU" term="%22Hamie+M%22">Hamie M</searchLink>; Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.; Center for Drug Discovery, American University of Beirut, Beirut, Lebanon.<br /><searchLink fieldCode="AU" term="%22El+Hajj+R%22">El Hajj R</searchLink>; Department of Biological Sciences, Beirut Arab University, Beirut, Lebanon.<br /><searchLink fieldCode="AU" term="%22Derbaj+G%22">Derbaj G</searchLink>; Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.; Center for Drug Discovery, American University of Beirut, Beirut, Lebanon.<br /><searchLink fieldCode="AU" term="%22Najm+R%22">Najm R</searchLink>; College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Makhoul+P%22">Makhoul P</searchLink>; Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.; Center for Drug Discovery, American University of Beirut, Beirut, Lebanon.<br /><searchLink fieldCode="AU" term="%22Ali+DH%22">Ali DH</searchLink>; Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.<br /><searchLink fieldCode="AU" term="%22Abou+Fayad+AG%22">Abou Fayad AG</searchLink>; Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.; Center for Drug Discovery, American University of Beirut, Beirut, Lebanon.<br /><searchLink fieldCode="AU" term="%22El+Hajj+H%22">El Hajj H</searchLink>; Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.; Center for Drug Discovery, American University of Beirut, Beirut, Lebanon. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2022 Oct 10; Vol. 13, pp. 1023114. <i>Date of Electronic Publication: </i>2022 Oct 10 (<i>Print Publication: </i>2022). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36299890 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fphar.2022.1023114 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1023114 Titles: – TitleFull: HAS 1: A natural product from soil-isolated Streptomyces species with potent activity against cutaneous leishmaniasis caused by Leishmania tropica. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Awada B – PersonEntity: Name: NameFull: Hamie M – PersonEntity: Name: NameFull: El Hajj R – PersonEntity: Name: NameFull: Derbaj G – PersonEntity: Name: NameFull: Najm R – PersonEntity: Name: NameFull: Makhoul P – PersonEntity: Name: NameFull: Ali DH – PersonEntity: Name: NameFull: Abou Fayad AG – PersonEntity: Name: NameFull: El Hajj H IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 10 Text: 2022 Oct 10 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 1663-9812 Numbering: – Type: volume Value: 13 Titles: – TitleFull: Frontiers in pharmacology Type: main |
| ResultId | 1 |